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ABSTRACT 
Objective: There is a considerable therapeutic interest in eIF5A as a potential target for drug development through inhibition of hypusination. In 
this regards, protein structural information is fundamental. Herein, we reported the developing of a web-based system, called eIF5ADB, which 
compiles all protein structural data on eIF5A and its related proteins.  
Methods: The eIF5ADB database was implemented as a MySQL relational database, using PHP scripting language. Web interfaces were developed 
using HTML, CSS and JavaScript. The data were collected from PDB, UniProt and Entrez databases. These data were filtered appropriately using 
specialized literature.  
Results: The database provides three modules that allow to search, acquisition of contents and access to statistical data, besides direct links to 
matching to external databases.  
Conclusion: The platform developed here is very useful for researchers interested in this content and can be accessed at http: //www. gurupi. uft. 
edu. br/btoxdb/eif5adb. 
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INTRODUCTION 
Translational control is very important in all organisms. The 
translation factor eIF5A is essential for cell viability and is highly 
conserved from archaea to mammals. This factor is the only protein 
known to contain the unusual amino acid hypusine [N ε- (4-amino-2-
hydroxybutyl)-lysine] that is essential for its biological activity [1]. 
This post-translational modification is dependent on the polyamine 
spermidine and is achieved by two sequential catalytic steps of the 
enzymes deoxyhypusine synthase (DHS) and deoxyhypusine 
hydroxylase (DOHH). Briefly, DHS catalyzes the formation of an 
intermediate (deoxyhypusine [Nε-(4-amino-butyl)-lysine] residue) 
by the transfer of the aminobutyl moiety of polyamine spermidine to 
one specific lysine residue of the eIF5A precursor. Subsequently, this 
intermediate is hydroxylated by DOHH to form hypusine-containing 
active eIF5A [1]. eIF5A promotes methionyl-puromycin synthesis in 
vitro, a model reaction for the formation of the first peptide bond. 
However, recently eIF5A has been implicated 
Deoxyhypusine and hypusine occur in archaea and eukaryotes, but 
not in eubacteria. However eubacteria has an elongation factor P 
(EF-P), which is an ortholog of eIF5A [3]. Similar to eIF5A that has a 
conserved lysine residue post-translationally modified to hypusine, 
EF-P has a corresponding lysine residue from at least some bacteria 
that is modified by the addition of a β-lysine moiety. This post-
translationally modification is called lysinylation and, as 
hypusination, is unique [2]. EF-P also promotes methionyl-
puromycin synthesis in vitro and has a significant amino acid 
sequence similarity with archaeal IF5A (aIF5A) and eIF5A[1]. EF-P is 
an essential protein in bacteria stimulating the peptidyl transferase 
activity of the ribosome, in the elongation step of the translation [4]. 
Recently, was also implicated to play a role in the relief of ribosome 
stalling caused by specific amino acid sequences [5]. Furthermore, 
EF-P has been indicated to play an auxiliary role that is required for 
virulence and resistance to multiple forms of stress [6].  
in translation 
elongation instead of initiation [2].  
Since eIF5A is important in protein translation and the hypusine is 
essential for its biological activity, disruption of the hypusination is 
of considerable interest as a strategy against many human disorders 
[7,8]. Mutants of eIF5A that cannot be hypusinated induce apoptosis 
in numerous cancer cell types including colon, cervical, skin, and 
lung cancer [7, 9, 10]. Clinical drugs ciclopirox and deferiprone could 
impair transcription from HIV-1 promoters and decrease HIV-1 gene 
expression by inhibiting eIF5A hypusination [11]. Furthermore, 
eIF5A is proposed as a potential cellular target to improving several 
anti-inflammatory treatments [12, 13]. 
Currently, there is a diminished the overall capacity to generate 
novel drugs because pharmaceutical companies have dedicated 
major efforts to obtain new versions of old drug classes, abandoning 
the programs of development of new types directed towards 
unexplored targets.  
There is a need for alternative drugs to improve treatments in many 
human disorders. Considering the importance of eIF5a and its 
related proteins as new potential unexplored targets for 
development of alternative drugs and the importance of structural 
data for this purpose, here is presented a web-based system, called 
eIF5ADB, that was created to maintain a resource of all available 
protein structural information of these proteins.  
The database provides three modules: i) a “Search” module, which 
perform a search from keywords; ii) a “Browse” module, which 
return data from predefined options; iii) a “Statistics” module, which 
return statistics data from the database. The eIF5aDB is a record-
based database. It was implemented as a MySQL relational database, 
running on a Linux platform with an Apache web-server. Web 
interfaces were developed using HTML, CSS and JavaScript 
languages. All charts were constructed with Google Charts (https: 
//developers. google. com/chart/). The eIF5aDB database is 
managed and updated using the SQL and PHP scripting languages. 
The data were collected from PDB (http: //www. rcsb. 
org/pdb/home/home. do), UniProt (www. uniprot. org) and Entrez 
(http: //www. ncbi. nlm. nih. gov) databases. All data from these 
databases were extracted using keyword and sequence homology 
searches. These data were filtered appropriately using specialized 
literature. 
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Fig. 1: Examples of use "Search" and "Browse" modules. A) An 
example of the results of a search of articles using the term 
“elongation factor P”. B) An example of the results for “Homo 
sapiens”, using "Browse" module. 
 
The modules named “Search” and “Browse” were developed to allow 
queries on entries deposited in the eIF5ADB database, allowing 
preset if the user is only interested in literature search or only 
interested in data of structures from crystallography or NMR 
experiments. The "Search" module should be used when the user is 
interested in data search from keywords and without any filtering 
by taxonomy or specific organisms. The "Browse" module should be 
used when the user is interested in browse the complete listing of 
eIF5ADB database entries or browse all data from one or more 
taxonomy (archaea, eubacteria or eukaryota) or one or more 
species. 
In both tools, the literature search initially returns entries in a table 
(Figure 1A) and each result is displayed in one row of the table, 
containing information about title, authors and journal. The 
complete reference of selected entries can be downloaded using the 
"Get references" button on the bottom of the display page. For each 
entries, on the right of the display page, a “more” option allows to 
see detailed content, which display PMID and DOI numbers, both 
allowing link to respectively external databases, and the abstract of 
the reference. If is searched data of structures, in both modules, a 
screen is showed with the data in a table containing information 
about PDB ID, molecule name and organism (Figure 1B). The PDB 
files or primary sequences of selected entries can be downloaded 
using the "Get PDBs" and "Get sequences" buttons, respectively, on 
the bottom of the display page. For each entry, on the right of the 
display page, a “more” option allows to see detailed content of each 
structure, in a new screen, including experimental data, molecule 
names, primary sequences and article related. 
The module named “Statistics” provides the researcher a way to 
obtain statistical data from solved structures on eIF5A and its 
related proteins. In this module, it is possible to obtain statistical 
data grouped by taxonomy (archaea, eubacteria or eukaryota), 
organisms or protein type (eIF5A/aIF5A, EF-P or any enzymes 
related). The Table 1 shows current 3D structures of eIF5A and its 
related proteins, grouped by protein type, based on data collected 
and processed from the eIF5ADB database.  
The compilation of all structural data on eIF5A and its related 
proteins in one platform is very useful for researchers interested in 
this content, allowing search, acquisition of contents and access to 
statistical data, besides direct links to match to external databases. 
The eIF5ADB database is available to the public and can be accessed 
at http: //www. gurupi. uft. edu. br/btoxdb/eif5adb. The database 
will be updated on a monthly according on new structural data on 
eIF5A and its related proteins were published. New tools can be 
incorporated to allow additional data analysis. 
Table 1: Current 3D structures of eIF5A and related proteins grouped by protein type. All data were collected and processed from the 
eIF5ADB database. 
Protein type PDB ID Chain ID Experimental method 
Desoxyhypusine synthase (DHS) 1DHS A X-ray 
1RLZ A X-ray 
1ROZ A, B X-ray 
1RQD A, B X-ray 
Elongation factor P (EF-P) 1UEB A, B X-ray 
1YBY A, B X-ray 
3HUW V X-ray 
3HUY V X-ray 
3A5Z B, D, F, H X-ray 
3OYY A, B X-ray 




3A5Y A, B, C, D X-ray 
3A5Z A, C, E, G X-ray 
3G1Z A, B X-ray 
Translation initiation factor 5A (eIF5A or aIF5A) 
 
1IZ6 A, B, C X-ray 
2EIF A X-ray 
1BKB A X-ray 
1EIF A X-ray 
1XTD A X-ray 
1X6O A X-ray 
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aIF5A - Archaeal initiation factor 5A, CSS - Cascading Style Sheet, 
DHS - Deoxyhypusine synthase, DOHH -Deoxyhypusine hydroxylase, 
EF-P -Elongation factor P, eIF5A -Eukaryotic translation initiation 
factor 5A, HTML - Hypertext Markup Language, PDB -Protein Data 
Bank, PHP -Hypertext Preprocessor, SQL -Structured Query 
Language 
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